Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd Therapy Administered Into Lymph Nodes Combined With Oral Vitamin D to Investigate the Impact on the Progression of Type 1 Diabetes

NCT03345004 is registered in ClinicalTrials.gov with Diamyd Medical AB as lead sponsor.

NCT NCT03345004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03345004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd Therapy Administered Into Lymph Nodes Combined With Oral Vitamin D to Investigate the Impact on the Progression of Type 1 Diabetes
Lead sponsor
Diamyd Medical AB
Phase
Phase 2
Overall status
Completed
Start date
December 20, 2017
Completion date
April 27, 2021
Enrollment
109 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diabetes, autoimmune diseases, diabetes mellitus, diabetes mellitus, type 1, endocrine system diseases, glucose metabolism disorders, immune system diseases, insulin dependent diabetes, juvenile diabetes, metabolic disease, physiological effects of drugs, vitamin d